MXPA03000278A - Uso de cepas de parapoxvirus ovis frente a fibrosis de organos. - Google Patents
Uso de cepas de parapoxvirus ovis frente a fibrosis de organos.Info
- Publication number
- MXPA03000278A MXPA03000278A MXPA03000278A MXPA03000278A MXPA03000278A MX PA03000278 A MXPA03000278 A MX PA03000278A MX PA03000278 A MXPA03000278 A MX PA03000278A MX PA03000278 A MXPA03000278 A MX PA03000278A MX PA03000278 A MXPA03000278 A MX PA03000278A
- Authority
- MX
- Mexico
- Prior art keywords
- vapes
- liver
- organ fibrosis
- parapoxvirus ovis
- against organ
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title abstract 2
- 206010016654 Fibrosis Diseases 0.000 title 1
- 241000283898 Ovis Species 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invencion se refiere al uso en seres humanos de parapoxvirus inactivados en la profilaxis y el tratamiento de enfermedades que estan acompanadas por una elevada deposicion de colageno, pudiendo estar afectados tanto organos internos, por ejemplo el higado, como la piel y sus anejos. Se refiere especialmente a fibrosis hepatica o a cirrosis hepatica como consecuencia de hepatitis viral o a enfermedades hepaticas inducidas por el etanol, asi como a fibrosis quistica.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10033581 | 2000-07-11 | ||
| DE10122233A DE10122233A1 (de) | 2000-07-11 | 2001-05-08 | Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen |
| PCT/EP2001/007978 WO2002004019A2 (de) | 2000-07-11 | 2001-07-11 | Verwendung von stämmen des parapoxvirus ovis gegen organfibrosen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03000278A true MXPA03000278A (es) | 2004-04-05 |
Family
ID=26006334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03000278A MXPA03000278A (es) | 2000-07-11 | 2001-07-11 | Uso de cepas de parapoxvirus ovis frente a fibrosis de organos. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6632647B2 (es) |
| EP (1) | EP1303302B1 (es) |
| JP (1) | JP5106736B2 (es) |
| CN (1) | CN1452496B (es) |
| AR (1) | AR028800A1 (es) |
| AU (2) | AU8582701A (es) |
| BG (1) | BG107447A (es) |
| CA (1) | CA2415399C (es) |
| CZ (1) | CZ200372A3 (es) |
| DK (1) | DK200300014A (es) |
| EE (1) | EE200300019A (es) |
| FI (1) | FI20030038A7 (es) |
| GB (1) | GB2383752B (es) |
| HK (1) | HK1054330B (es) |
| HR (1) | HRP20030097A2 (es) |
| HU (1) | HU227668B1 (es) |
| IL (1) | IL153826A0 (es) |
| LT (1) | LT5064B (es) |
| LU (1) | LU90996B1 (es) |
| LV (1) | LV12991B (es) |
| MA (1) | MA25765A1 (es) |
| MX (1) | MXPA03000278A (es) |
| NO (1) | NO20030081L (es) |
| NZ (1) | NZ523535A (es) |
| PL (1) | PL360839A1 (es) |
| RU (1) | RU2003104522A (es) |
| SE (1) | SE0300033L (es) |
| SI (1) | SI21171A (es) |
| SK (1) | SK382003A3 (es) |
| WO (1) | WO2002004019A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
| US6752995B2 (en) | 2002-04-15 | 2004-06-22 | Board Of Regents, The University Of Texas System | Nucleic acid and polypeptide sequences useful as adjuvants |
| US6844000B2 (en) | 2001-12-07 | 2005-01-18 | Bayer Pharmaceuticals Corporation | Use of Parapox B2L protein to treat cancer and modify immune responses |
| EP1574211A1 (en) | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| WO2012045473A1 (en) * | 2010-10-07 | 2012-04-12 | Technische Universität München | Viruses for the treatment of fibrosis |
| KR20180129779A (ko) * | 2016-02-16 | 2018-12-05 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 섬유화를 치료하기 위한 의약 조성물 |
| TW201919675A (zh) * | 2017-09-07 | 2019-06-01 | 德商艾庫瑞斯公司 | 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
| US4360510A (en) * | 1979-11-30 | 1982-11-23 | Proctor Julian W | Method for screening anti-tumor agents of the reticulo-endothelial stimulant class |
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| DE3504940C2 (de) | 1984-02-17 | 1997-11-06 | Bayer Ag | Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel |
| DE3816139A1 (de) * | 1987-10-17 | 1989-04-27 | Bayer Ag | Verfahren zur herstellung von paramunitaetsinducern |
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| BR9708679A (pt) * | 1996-04-15 | 2000-01-04 | Anton Mayr | Uso de indutores de pox, e, processo para tratamento auxiliar de pacientes submetidos à quimioterapia ou radioterapia. |
| DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
| IL139593A (en) * | 2000-11-09 | 2010-12-30 | Biogem Optical Ltd | Method for the detection of viable microorganisms |
-
2001
- 2001-07-11 LU LU90996A patent/LU90996B1/en active
- 2001-07-11 SI SI200120047A patent/SI21171A/sl not_active IP Right Cessation
- 2001-07-11 IL IL15382601A patent/IL153826A0/xx active IP Right Grant
- 2001-07-11 GB GB0302629A patent/GB2383752B/en not_active Expired - Lifetime
- 2001-07-11 FI FI20030038A patent/FI20030038A7/fi not_active IP Right Cessation
- 2001-07-11 EE EEP200300019A patent/EE200300019A/xx unknown
- 2001-07-11 HR HR20030097A patent/HRP20030097A2/xx not_active Application Discontinuation
- 2001-07-11 US US09/903,005 patent/US6632647B2/en not_active Expired - Lifetime
- 2001-07-11 HU HU0303830A patent/HU227668B1/hu not_active IP Right Cessation
- 2001-07-11 NZ NZ52353501A patent/NZ523535A/xx unknown
- 2001-07-11 EP EP01965110A patent/EP1303302B1/de not_active Expired - Lifetime
- 2001-07-11 AR ARP010103291A patent/AR028800A1/es not_active Application Discontinuation
- 2001-07-11 PL PL36083901A patent/PL360839A1/xx not_active Application Discontinuation
- 2001-07-11 JP JP2002508473A patent/JP5106736B2/ja not_active Expired - Lifetime
- 2001-07-11 HK HK03106614.0A patent/HK1054330B/zh not_active IP Right Cessation
- 2001-07-11 MX MXPA03000278A patent/MXPA03000278A/es active IP Right Grant
- 2001-07-11 AU AU8582701A patent/AU8582701A/xx active Pending
- 2001-07-11 CA CA2415399A patent/CA2415399C/en not_active Expired - Lifetime
- 2001-07-11 WO PCT/EP2001/007978 patent/WO2002004019A2/de not_active Ceased
- 2001-07-11 RU RU2003104522/15A patent/RU2003104522A/ru not_active Application Discontinuation
- 2001-07-11 AU AU2001285827A patent/AU2001285827B2/en not_active Expired
- 2001-07-11 CZ CZ200372A patent/CZ200372A3/cs unknown
- 2001-07-11 CN CN018151272A patent/CN1452496B/zh not_active Expired - Lifetime
- 2001-07-11 SK SK38-2003A patent/SK382003A3/sk not_active Application Discontinuation
-
2003
- 2003-01-08 BG BG107447A patent/BG107447A/bg unknown
- 2003-01-08 NO NO20030081A patent/NO20030081L/no not_active Application Discontinuation
- 2003-01-10 DK DK200300014A patent/DK200300014A/da not_active Application Discontinuation
- 2003-01-10 SE SE0300033A patent/SE0300033L/xx not_active Application Discontinuation
- 2003-01-10 MA MA26995A patent/MA25765A1/fr unknown
- 2003-02-03 LT LT2003008A patent/LT5064B/lt not_active IP Right Cessation
- 2003-02-11 LV LVP-03-13A patent/LV12991B/lv unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0208142A (pt) | Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona | |
| BR0107748A (pt) | Composições antimicrobianas | |
| ECSP099447A (es) | Derivados indólicos con anillo unido en las posiciones 4,5 y sus métodos de uso | |
| CY1105127T1 (el) | Συνθεση για την προληψη καρδιαγγειακων νοσων | |
| UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
| BRPI0411900A (pt) | compostos antivirais e métodos | |
| CO5060498A1 (es) | Composicion plaguicida sinergica que comprende emamectina (a) | |
| DE60106954D1 (de) | Resorcin-derivate | |
| HN2001000027A (es) | Derivados de purina | |
| AR030829A1 (es) | Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal | |
| NO20034878D0 (no) | Antivirale forbindelser | |
| ES2165269A1 (es) | Derivados de alfa-cetoamidas. | |
| AR034752A1 (es) | Proceso de control de malezas | |
| BR0108499A (pt) | Agente terapêutico para hepatite c | |
| MXPA03000278A (es) | Uso de cepas de parapoxvirus ovis frente a fibrosis de organos. | |
| BR0110689A (pt) | Composição fungicida, e, métodos para intensificar a atividade fungicida de etaboxam, e para controlar fitopatógenos indesejados | |
| BR0111729A (pt) | 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais | |
| ES2176263T3 (es) | 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. | |
| GT200600262A (es) | Uso de la sangliferina en el hcv (virus de la hepatitis "c") | |
| MXPA02011969A (es) | Metodos para el tratamiento de padecimientos virales con il-18 y combinaciones de il-18. | |
| AR031505A1 (es) | Un producto de cereal y/o legumbre y el procedimiento para prepararlo | |
| PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
| BR0207434A (pt) | Uso de agentes de domiciliação acelerada de linfócitos para a fabricação de um medicamento para o tratamento de função retardada de enxertos | |
| UY26833A1 (es) | Uso de cepas de parapoxvirus ovis contra fibrosis de órganos | |
| BR0009194A (pt) | Composição do resorcinol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights | ||
| FG | Grant or registration | ||
| HH | Correction or change in general |